| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233241 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 6 Pages |
Abstract
Short-term ADT and RT might be acceptable for men with intermediate- and high-risk prostate cancer, especially for clinically localized disease treated with doses of â¥74 Gy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Stanley L. M.D., Walter M. M.D., David B.S., Ralph R. M.D., Ashesh B. M.D.,